Role of complement in host-microbe homeostasis of the periodontium

Seminars in Immunology

Volumn 25, Issue 1, 2013, Pages 65-72

  Hajishengallis, George ^a   Abe, Toshiharu ^a   Maekawa, Tomoki ^a   Hajishengallis, Evlambia ^a   Lambris, John D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C5a receptor; Complement; Dysbiosis; Periodontitis; Porphyromonas gingivalis

Indexed keywords

COMPLEMENT;

BACTERIUM IDENTIFICATION; HOMEOSTASIS; HOST MICROBE HOMEOSTASIS; HUMAN; INFLAMMATION; MICROBIAL COMMUNITY; MICROFLORA; NONHUMAN; PERIODONTITIS; PERIODONTIUM; REVIEW;

C5A RECEPTOR; COMPLEMENT; DYSBIOSIS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COMPLEMENT SYSTEM PROTEINS; DYSBIOSIS; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIOTA; PERIODONTITIS; PERIODONTIUM; RECEPTOR, ANAPHYLATOXIN C5A; SIGNAL TRANSDUCTION;

EID: 84879887362     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.04.004     Document Type: Review

References (128)

1. Li K., Sacks S.H., Zhou W. The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Molecular Immunology 2007, 44:3866-3874.
2. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nature Immunology 2010, 11:785-797.
3. Hajishengallis G., Lambris J.D. Crosstalk pathways between toll-like receptors and the complement system. Trends in Immunology 2010, 31:154-163.
4. Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime. Trends in Immunology 2007, 28:184-192.
5. Jalili A., Shirvaikar N., Marquez-Curtis L., Qiu Y., Korol C., Lee H., et al. Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Experimental Hematology 2010, 38:321-332.
6. Lee H.M., Wysoczynski M., Liu R., Shin D.M., Kucia M., Botto M., et al. Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes. Leukemia 2009, 24:573-582.
7. Dunkelberger J.R., Song W.C. Complement and its role in innate and adaptive immune responses. Cell Research 2010, 20:34-50.
8. Friec G.L., Kemper C. Complement: coming full circle. Archivum Immunologiae et Therapiae Experimentalis 2009, 57:393-407.
9. Spitzer D., Mitchell L.M., Atkinson J.P., Hourcade D.E. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. Journal of Immunology 2007, 179:2600-2608.
10. Kimura Y., Miwa T., Zhou L., Song W.-C. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 2008, 111:732-740.
11. Harboe M., Mollnes T.E. The alternative complement pathway revisited. Journal of Cellular and Molecular Medicine 2008, 12:1074-1084.
12. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nature Reviews Immunology 2009, 9:729-740.
13. Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. Journal of Immunology 2013, 190:3831-3838.
14. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nature Reviews Microbiology 2008, 6:132-142.
15. Potempa J., Pike R.N. Corruption of innate immunity by bacterial proteases. Journal of Innate Immunity 2009, 1:70-87.
16. Krauss J.L., Potempa J., Lambris J.D., Hajishengallis G. Complementary tolls in the periodontium: how periodontal bacteria modify complement and toll-like receptor responses to prevail in the host. Periodontology 2010, 52:141-162.
17. Hajishengallis G., Lambris J.D. Microbial manipulation of receptor crosstalk in innate immunity. Nature Reviews Immunology 2011, 11:187-200.
18. Hajishengallis G. Complement and periodontitis. Biochemical Pharmacology 2010, 80:1992-2001.
19. Pihlstrom B.L., Michalowicz B.S., Johnson N.W. Periodontal diseases. Lancet 2005, 366:1809-1820.
20. Hajishengallis G., Lamont R.J. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Molecular Oral Microbiology 2012, 27:409-419.
21. Eke P.I., Dye B.A., Wei L., Thornton-Evans G.O., Genco R.J. Prevalence of periodontitis in adults in the United States: 2009 and 2010. Journal of Dental Research 2012, 91:914-920.
22. Genco R.J., Van Dyke T.E. Prevention reducing the risk of CVD in patients with periodontitis. Nature Reviews Cardiology 2010, 7:479-480.
23. Tonetti M.S., D'Aiuto F., Nibali L., Donald A., Storry C., Parkar M., et al. Treatment of periodontitis and endothelial function. New England Journal of Medicine 2007, 356:911-920.
24. Lundberg K., Wegner N., Yucel-Lindberg T., Venables P.J. Periodontitis in RA-the citrullinated enolase connection. Nature Reviews Rheumatology 2010, 6:727-730.
25. Lalla E., Papapanou P.N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nature Reviews Endocrinology 2011, 7:738-748.
26. Moore W.E., Holdeman L.V., Smibert R.M., Hash D.E., Burmeister J.A., Ranney R.R. Bacteriology of severe periodontitis in young adult humans. Infection and Immunity 1982, 38:1137-1148.
27. Socransky S.S. Microbiology of periodontal disease - present status and future considerations. Journal of Periodontology 1977, 48:497-504.
28. Tanner A.C.R., Haffer C., Bratthall G.T., Visconti R.A., Socransky S.S. Study of the bacteria associated with advancing periodontitis in man. Journal of Clinical Periodontology 1979, 6:278-307.
29. Slots J. Microflora in the healthy gingival sulcus in man. Scandinavian Journal of Dental Research 1977, 85:247-254.
30. Slots J. The predominant cultivable microflora of advanced periodontitis. Scandinavian Journal of Dental Research 1977, 85:114-121.
31. Moore W.E., Holdeman L.V., Cato E.P., Smibert R.M., Burmeister J.A., Ranney R.R. Bacteriology of moderate (chronic) periodontitis in mature adult humans. Infection and Immunity 1983, 42:510-515.
32. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Kent R.L. Microbial complexes in subgingival plaque. Journal of Clinical Periodontology 1998, 25:134-144.
33. Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C., Yu W.H., et al. The human oral microbiome. Journal of Bacteriology 2010, 192:5002-5017.
34. Griffen A.L., Beall C.J., Firestone N.D., Gross E.L., Difranco J.M., Hardman J.H., et al. CORE: a phylogenetically-curated 16S rDNA database of the core oral microbiome. PLoS One 2011, 6:e19051.
35. Curtis M.A., Zenobia C., Darveau R.P. The relationship of the oral microbiotia to periodontal health and disease. Cell Host Microbe 2011, 10:302-306.
36. Kumar P.S., Griffen A.L., Barton J.A., Paster B.J., Moeschberger M.L., Leys E.J. New bacterial species associated with chronic periodontitis. Journal of Dental Research 2003, 82:338-344.
37. Kumar P.S., Griffen A.L., Moeschberger M.L., Leys E.J. Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. Journal of Clinical Microbiology 2005, 43:3944-3955.
38. Paster B.J., Boches S.K., Galvin J.L., Ericson R.E., Lau C.N., Levanos V.A., et al. Bacterial diversity in human subgingival plaque. Journal of Bacteriology 2001, 183:3770-3783.
39. Griffen A.L., Beall C.J., Campbell J.H., Firestone N.D., Kumar P.S., Yang Z.K., et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME Journal 2012, 6:1176-1185.
40. Kumar P.S., Leys E.J., Bryk J.M., Martinez F.J., Moeschberger M.L., Griffen A.L. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. Journal of Clinical Microbiology 2006, 44:3665-3673.
41. Darveau R.P. Periodontitis: a polymicrobial disruption of host homeostasis. Nature Reviews Microbiology 2010, 8:481-490.
42. Lamster I.B., Ahlo J.K. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Annals of the New York Academy of Sciences 2007, 1098:216-229.
43. Delima A.J., Van Dyke T.E. Origin and function of the cellular components in gingival crevice fluid. Periodontology 2000 2003, 31:55-76.
44. Popadiak K., Potempa J., Riesbeck K., Blom A.M. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. Journal of Immunology 2007, 178:7242-7250.
45. Schenkein H.A., Genco R.J. Complement cleavage products in inflammatory exudates from patients with periodontal diseases. Journal of Immunology 1978, 120:1796.
46. Schenkein H.A., Genco R.J. Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid. Journal of Periodontology 1977, 48:778-784.
47. Lally E.T., McArthur W.P., Baehni P.C. Biosynthesis of complement components in chronically inflamed gingiva. Journal of Periodontal Research 1982, 17:257-262.
48. Slaney J.M., Curtis M.A. Mechanisms of evasion of complement by Porphyromonas gingivalis. Frontiers in Bioscience 2008, 13:188-196.
49. Blom A.M., Hallstrom T., Riesbeck K. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Molecular Immunology 2009, 46:2808-2817.
50. Slaney J.M., Gallagher A., Aduse-Opoku J., Pell K., Curtis M.A. Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infection and Immunity 2006, 74:5352-5361.
51. Schenkein H.A. Complement factor D-like activity of Porphyromonas gingivalis W83. Oral Microbiology and Immunology 1991, 6:216-220.
52. Paramonov N., Rangarajan M., Hashim A., Gallagher A., Aduse-Opoku J., Slaney J.M., et al. Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipain glycans. Molecular Microbiology 2005, 58:847-863.
53. Potempa M., Potempa J., Kantyka T., Nguyen K.A., Wawrzonek K., Manandhar S.P., et al. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathogens 2009, 5:e1000316.
54. Kamaguch A., Nakayama K., Ohyama T., Watanabe T., Okamoto M., Baba H. Coaggregation of Porphyromonas gingivalis and Prevotella intermedia. Microbiology and Immunology 2001, 45:649-656.
55. Kamaguchi A., Ohyama T., Sakai E., Nakamura R., Watanabe T., Baba H., et al. Adhesins encoded by the gingipain genes of Porphyromonas gingivalis are responsible for co-aggregation with Prevotella intermedia. Microbiology 2003, 149:1257-1264.
56. Sharma A. Virulence mechanisms of Tannerella forsythia. Periodontology 2000 2010, 54:106-116.
57. Jusko M., Potempa J., Karim A.Y., Ksiazek M., Riesbeck K., Garred P., et al. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. Journal of Immunology 2012, 188:2338-2349.
58. Potempa M., Potempa J., Okroj M., Popadiak K., Eick S., Nguyen K.A., et al. Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. Journal of Immunology 2008, 181:5537-5544.
59. Asakawa R., Komatsuzawa H., Kawai T., Yamada S., Goncalves R.B., Izumi S., et al. Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans. Molecular Microbiology 2003, 50:1125-1139.
60. Malm S., Jusko M., Eick S., Potempa J., Riesbeck K., Blom A.M. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia. PLoS One 2012, 7:e34852.
61. McDowell J.V., Huang B., Fenno J.C., Marconi R.T. Analysis of a unique interaction between the complement regulatory protein factor H and the periodontal pathogen Treponema denticola. Infection and Immunity 2009, 77:1417-1425.
62. Yamazaki T., Miyamoto M., Yamada S., Okuda K., Ishihara K. Surface protease of Treponema denticola hydrolyzes C3 and influences function of polymorphonuclear leukocytes. Microbes and Infection 2006, 8:1758-1763.
63. Schenkein H.A., Berry C.R. Activation of complement by Treponema denticola. Journal of Dental Research 1991, 70:107-110.
64. Mevorach D., Mascarenhas J.O., Gershov D., Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. Journal of Experimental Medicine 1998, 188:2313-2320.
65. Kim S., Elkon K.B., Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 2004, 21:643-653.
66. Wright S.D., Silverstein S.C. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. Journal of Experimental Medicine 1983, 158:2016-2023.
67. Berton G., Laudanna C., Sorio C., Rossi F. Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils. Journal of Cell Biology 1992, 116:1007-1017.
68. Ernst J.D. Macrophage receptors for Mycobacterium tuberculosis. Infection and Immunity 1998, 66:1277-1281.
69. Hellwig S.M., van Oirschot H.F., Hazenbos W.L., van Spriel A.B., Mooi F.R., van De Winkel J.G. Targeting to Fcγ receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. Journal of Infectious Diseases 2001, 183:871-879.
70. Hajishengallis G., McIntosh M.L., Nishiyama S-i, Yoshimura F. Mechanism and implications of CXCR4-mediated integrin activation by Porphyromonas gingivalis. Molecular Oral Microbiology 2012, 28. Epub ahead of print. 10.1111/omi.12021.
71. Wang M., Krauss J.L., Domon H., Hosur K.B., Liang S., Magotti P., et al. Microbial hijacking of complement-toll-like receptor crosstalk. Science Signalling 2010, 3:ra11.
72. Wingrove J.A., DiScipio R.G., Chen Z., Potempa J., Travis J., Hugli T.E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. Journal of Biological Chemistry 1992, 267:18902-18907.
73. Klos A., Tenner A.J., Johswich K.O., Ager R.R., Reis E.S., Kohl J. The role of the anaphylatoxins in health and disease. Molecular Immunology 2009, 46:2753-2766.
74. Snyderman R. Role for endotoxin and complement in periodontal tissue destruction. Journal of Dental Research 1972, 51:356-361.
75. Mahtout H., Chandad F., Rojo J.M., Grenier D. Porphyromonas gingivalis mediates the shedding and proteolysis of complement regulatory protein CD46 expressed by oral epithelial cells. Oral Microbiology and Immunology 2009, 24:396-400.
76. Mahtout H., Curt S., Chandad F., Rouabhia M., Grenier D. Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells. FEMS Immunology and Medical Microbiology 2011, 62:295-303.
77. Cardone J., Le Friec G., Vantourout P., Roberts A., Fuchs A., Jackson I., et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nature Immunology 2010, 11:862-871.
78. Cardone J., Le Friec G., Kemper C. CD46 in innate and adaptive immunity: an update. Clinical and Experimental Immunology 2011, 164:301-311.
79. Kolenbrander P.E., Palmer R.J., Periasamy S., Jakubovics N.S. Oral multispecies biofilm development and the key role of cell-cell distance. Nature Reviews Microbiology 2010, 8:471-480.
80. Socransky S.S., Haffajee A.D. Periodontal microbial ecology. Periodontology 2000 2005, 38:135-187.
81. Discipio R.G., Daffern P.J., Kawahara M., Pike R., Travis J., Hugli T.E., et al. Cleavage of human complement component C5 by cysteine proteinases from Porphyromonas (Bacteroides) gingivalis. Prior oxidation of C5 augments proteinase digestion of C5. Immunology 1996, 87:660-667.
82. Imamura T., Banbula A., Pereira P.J., Travis J., Potempa J. Activation of human prothrombin by arginine-specific cysteine proteinases (Gingipains R) from Porphyromonas gingivalis. Journal of Biological Chemistry 2001, 276:18984-18991.
83. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nature Medicine 2006, 12:682-687.
84. Liang S., Krauss J.L., Domon H., McIntosh M.L., Hosur K.B., Qu H., et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. Journal of Immunology 2011, 186:869-877.
85. Guo R.F., Ward P.A. Role of C5a in inflammatory responses. Annual Review of Immunology 2005, 23:821-852.
86. Abe T., Hosur K.B., Hajishengallis E., Reis E.S., Ricklin D., Lambris J.D., et al. Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist. Journal of Immunology 2012, 189:5442-5448.
87. Kagan J.C. "Complementing" toll signaling. Science Signalling 2010, 3:pe15.
88. Hajishengallis G., Liang S., Payne M.A., Hashim A., Jotwani R., Eskan M.A., et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011, 10:497-506.
89. Burns E., Bachrach G., Shapira L., Nussbaum G. Cutting edge TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. Journal of Immunology 2006, 177:8296-8300.
90. Darveau R.P., Hajishengallis G., Curtis M.A. Porphyromonas gingivalis as a potential community activist for disease. Journal of Dental Research 2012, 91:816-820.
91. Honda K. Porphyromonas gingivalis sinks teeth into the oral microbiota and periodontal disease. Cell Host Microbe 2011, 10:423-425.
92. Hajishengallis G., Darveau R.P., Curtis M.A. The keystone-pathogen hypothesis. Nature Reviews Microbiology 2012, 10:717-725.
93. Hasturk H., Kantarci A., Goguet-Surmenian E., Blackwood A., Andry C., Serhan C.N., et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Journal of Immunology 2007, 179:7021-7029.
94. Page R.C., Lantz M.S., Darveau R., Jeffcoat M., Mancl L., Houston L., et al. Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis. Oral Microbiology and Immunology 2007, 22:162-168.
95. Doungudomdacha S., Rawlinson A., Douglas C.W. Enumeration of Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans in subgingival plaque samples by a quantitative-competitive PCR method. Journal of Medical Microbiology 2000, 49:861-874.
96. Chaves E.S., Jeffcoat M.K., Ryerson C.C., Snyder B. Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy. Journal of Clinical Periodontology 2000, 27:897-903.
97. Moore W.E., Moore L.H., Ranney R.R., Smibert R.M., Burmeister J.A., Schenkein H.A. The microflora of periodontal sites showing active destructive progression. Journal of Clinical Periodontology 1991, 18:729-739.
98. Page R.C., Schroeder H.E. Periodontitis in man and other animals - A comparative review 1982, Karger.
99. Darveau R.P., Tanner A., Page R.C. The microbial challenge in periodontitis. Periodontology 2000 1997, 14:12-32.
100. Courts F.J., Boackle R.J., Fudenberg H.H., Silverman M.S. Detection of functional complement components in gingival crevicular fluid from humans with periodontal diseases. Journal of Dental Research 1977, 56:327-331.
101. Toto P.D., Lin L., Gargiulo A. Identification of C3a, IgG, IgM in inflamed human gingiva. Journal of Dental Research 1978, 57:696.
102. Nikolopoulou-Papaconstantinou A.A., Johannessen A.C., Kristoffersen T. Deposits of immunoglobulins, complement, and immune complexes in inflamed human gingiva. Acta Odontologica Scandinavica 1987, 45:187-193.
103. Rautemaa R., Meri S. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59). Journal of Dental Research 1996, 75:568-574.
104. Boackle R.J. The interaction of salivary secretions with the human complement system - a model for the study of host defense systems on inflamed mucosal surfaces. Critical Reviews in Oral Biology and Medicine 1991, 2:355-367.
105. Attstrom R., Laurel A.B., Lahsson U., Sjoholm A. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans. Journal of Periodontal Research 1975, 10:19-27.
106. Schenkein H.A., Genco R.J. Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins. Journal of Periodontology 1977, 48:772-777.
107. Challacombe S.J., Shirlaw P.J. Immunology of diseases of the oral cavity. Mucosal immunology 2005, 1517-1546. Elsevier Academic Press. J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee, L. Mayer (Eds.).
108. Patters M.R., Niekrash C.E., Lang N.P. Assessment of complement cleavage in gingival fluid during experimental gingivitis in man. Journal of Clinical Periodontology 1989, 16:33-37.
109. Beikler T., Peters U., Prior K., Eisenacher M., Flemmig T.F. Gene expression in periodontal tissues following treatment. BMC Medical Genomics 2008, 1:30.
110. Niekrash C.E., Patters M.R. Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy. Journal of Periodontal Research 1985, 20:268-275.
111. Hillebrandt S., Wasmuth H.E., Weiskirchen R., Hellerbrand C., Keppeler H., Werth A., et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nature Genetics 2005, 37:835-843.
112. Chai L., Song Y.-Q., Zee K.-Y., Leung W.K. Single nucleotide polymorphisms of complement component 5 and periodontitis. Journal of Periodontal Research 2010, 45:301-308.
113. Heitz-Mayfield L.J. Disease progression: identification of high-risk groups and individuals for periodontitis. Journal of Clinical Periodontology 2005, 32(Suppl. 6):196-209.
114. Hajishengallis G. Too old to fight? Aging and its toll on innate immunity. Molecular Oral Microbiology 2010, 25:25-37.
115. Kornman K.S. Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. American Journal of Clinical Nutrition 2006, 83:475S-483S.
116. Graves D.T., Fine D., Teng Y.T., Van Dyke T.E., Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. Journal of Clinical Periodontology 2008, 35:89-105.
117. Breivik T., Gundersen Y., Gjermo P., Taylor S.M., Woodruff T.M., Opstad P.K. Oral treatment with complement factor C5a receptor (CD88) antagonists inhibits experimental periodontitis in rats. Journal of Periodontal Research 2011, 46:643-647.
118. Brown L.J., Johns B.A., Wall T.P. The economics of periodontal diseases. Periodontology 2000 2002, 29:223-234.
119. Beikler T., Flemmig T.F. Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontology 2000 2011, 55:87-103.
120. Armitage G.C. Classifying periodontal diseases - a long-standing dilemma. Periodontology 2000 2002, 30:9-23.
121. Colombo A.P., Boches S.K., Cotton S.L., Goodson J.M., Kent R., Haffajee A.D., et al. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. Journal of Periodontology 2009, 80:1421-1432.
122. Wagner E., Frank M.M. Therapeutic potential of complement modulation. Nature Reviews Drug Discovery 2010, 9:43-56.
123. Ricklin D., Lambris J.D. Complement-targeted therapeutics. Nature Biotechnology 2007, 25:1265-1275.
124. Immunology Leslie M. The new view of complement. Science 2012, 337:1034-1037.
125. Ricklin D., Lambris J.D. Progress and trends in complement therapeutics. Advances in Experimental Medicine and Biology 2013, 734:1-22.
126. Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: therapeutic interventions. Journal of Immunology 2013, 190:3839-3847.
127. Niekrash C.E., Patters M.R. Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease. Journal of Periodontal Research 1986, 21:233-242.
128. Hajishengallis G. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics. Microbes and Infection 2009, 11:637-645.